{"DataElement":{"publicId":"4841814","version":"1","preferredName":"Interleukin-2 Not Given Reason","preferredDefinition":"Brief explanation for not administering a dose of Interleukin-2 (IL-2).","longName":"IL2_NOTGIV_RSN","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4841714","version":"1","preferredName":"Administration Interleukin-2 Not Given Reason","preferredDefinition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses._Indicates a task, process or examination that has either not been initiated or not been completed._An explanation of the cause of some phenomenon or action.","longName":"4841712v1.0:2608537v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4841712","version":"1","preferredName":"Administration Interleukin-2","preferredDefinition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.:Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.","longName":"C25409:C20507","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-2","conceptCode":"C20507","definition":"Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17272F41-9BE8-9D2F-E050-BB89AD433AEF","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2608537","version":"1","preferredName":"Not Done Reason","preferredDefinition":"No Value Exists:An explanation of the cause of some phenomenon or action.","longName":"C49484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AF62F39-7742-2016-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-03-05","modifiedBy":"ONEDATA","dateModified":"2007-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17272F41-9BF6-9D2F-E050-BB89AD433AEF","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4841758","version":"1","preferredName":"Interleukin Not Given Reason","preferredDefinition":"Interleukin is the generic name for a group of well-characterized cytokines that are produced by leukocytes and other cell types.  They have a broad spectrum of functional activities that regulate the activities and capabilities of a wide variety of cell types.  They are particularly important as members of the cytokine networks that regulate inflammatory and immune responses._Indicates a task, process or examination that has either not been initiated or not been completed._An explanation of the cause of some phenomenon or action.","longName":"IL_NOTGIV_RSN","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No IL-2 indicated by protocol","valueDescription":"No Interleukin-2","ValueMeaning":{"publicId":"4841759","version":"1","preferredName":"No Interleukin-2","longName":"4841759","preferredDefinition":"The non-affirmative response to a question.: Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-2","conceptCode":"C20507","definition":"Interleukin-2 (153 aa, ~18 kDa) is encoded by the human IL2 gene. This protein is involved in T-cell proliferation, leukocyte stimulation and immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1726FB99-7C80-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1726FB99-7C99-6662-E050-BB89AD43074F","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","deletedIndicator":"No"},{"value":"Poor tolerance to cells","valueDescription":"Peripheral Blood Cell Intolerance","ValueMeaning":{"publicId":"4841760","version":"1","preferredName":"Peripheral Blood Cell Intolerance","longName":"4841760","preferredDefinition":"A general term describing the three cellular components of blood (white blood cells, red blood cells, and platelets), all which are made in the bone marrow. (Lymphoma Information Network Glossary): An inability to absorb or metabolize certain substances in the normal way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Blood Cell","conceptCode":"C12519","definition":"A general term describing the three cellular components of blood (white blood cells, red blood cells, and platelets), all which are made in the bone marrow. (Lymphoma Information Network Glossary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intolerance","conceptCode":"C71437","definition":"An inability to absorb or metabolize certain substances in the normal way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1726FB99-7CA6-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1726FB99-7CBF-6662-E050-BB89AD43074F","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","deletedIndicator":"No"},{"value":"Poor tolerance to preparative regimen","valueDescription":"Preparative Regimen Intolerance","ValueMeaning":{"publicId":"4841761","version":"1","preferredName":"Preparative Regimen Intolerance","longName":"4841761","preferredDefinition":"The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur: An inability to absorb or metabolize certain substances in the normal way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intolerance","conceptCode":"C71437","definition":"An inability to absorb or metabolize certain substances in the normal way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1726FB99-7CCC-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1726FB99-7CE5-6662-E050-BB89AD43074F","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4841757","version":"1","preferredName":"Interleukin Not Done Reason","preferredDefinition":"Interleukin is the generic name for a group of well-characterized cytokines that are produced by leukocytes and other cell types.  They have a broad spectrum of functional activities that regulate the activities and capabilities of a wide variety of cell types.  They are particularly important as members of the cytokine networks that regulate inflammatory and immune responses.:Indicates a task, process or examination that has either not been initiated or not been completed.:An explanation of the cause of some phenomenon or action.","longName":"C20497:C49484:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interleukin","conceptCode":"C20497","definition":"Interleukin is the generic name for a group of well-characterized cytokines that are produced by leukocytes and other cell types.  They have a broad spectrum of functional activities that regulate the activities and capabilities of a wide variety of cell types.  They are particularly important as members of the cytokine networks that regulate inflammatory and immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1726FB99-7C59-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1726FB99-7C6A-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"ONEDATA","dateModified":"2015-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason IL-2 not given","type":"Preferred Question Text","description":"Reason IL-2 not given","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1726FB99-7CEF-6662-E050-BB89AD43074F","latestVersionIndicator":"Yes","beginDate":"2015-05-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-05-28","modifiedBy":"REEVESD","dateModified":"2015-05-28","changeDescription":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}